| Literature DB >> 35892532 |
Urszula Kaczor1, Sebastian Sawicki1, Joanna Nowak2, Julia Gabryś1, Jakub Jurczyk1, Dorota Wojtysiak3, Katarzyna Połtowicz2.
Abstract
The effect of the g.4290 C>G substitution in the FADS2 gene and g.285 C>T in the FABP4 gene on carcass quality, meat quality, and fatty acid profile of the pectoralis superficialis muscle of 238 male broiler chickens reared up to 45 days of age was analyzed. A significant influence of g.4290 C>G in the FADS2 gene on the pectoralis superficialis muscle fatty acid profile was demonstrated. Chickens with the GG genotype were characterized by the highest content of conjugated linoleic acid, amino acids, eicosapentaenoic acids, docosapentaenoic acid, docosahexaenoic acids. and the lowest value of the linoleic acid/alpha-linolenic acid ratio. The FABP4 polymorphism determined only the content of C18:1n-9, C18:2n-6 and docosahexaenoic acid. There was no effect of the studied genotypes on final body weight, carcass quality traits, or quality of broiler pectoral muscles.Entities:
Keywords: FABP4; FADS2; broiler chicken; fatty acids; gene polymorphism; meat quality
Year: 2022 PMID: 35892532 PMCID: PMC9332055 DOI: 10.3390/ani12151882
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 3.231
Details of single-nucleotide polymorphism markers, genes, primers.
| Gene | Chr | SNP | Primers (5′ to 3′) | Ta (°C) | Enzyme | Tt (°C) | Product PCR/Genotype |
|---|---|---|---|---|---|---|---|
|
| 5 | g.4290 C>G | F: TGAACTGAAGCGTTTGATGG | 57.5 | 37 | 283 bp | |
|
| 2 | g.285 C>T | F: TGTGACTACTGGCAAAGGA | 63.5 | 65 | 477 bp |
Chr, Chromosome; FADS2, fatty acid desaturase 2 (NCBI Ref. Seq. NW_001471700); FABP4, fatty acid binding protein 4 (NCBI Ref. Seq. NC_006089); PCR, polymerase chain reaction; Ta, annealing temperature; Tt, pickling temperature; SNP, single-nucleotide polymorphism.
Least squares ± S.E. for broiler rearing performance, dressing percentage, carcass quality and pectoralis superficialis muscle quality parameters of FADS2 and FABP4 polymorphism.
| Traits | ||||||
|---|---|---|---|---|---|---|
| CC | CG | GG | CC | CT | TT | |
|
| ||||||
| BW (kg) | 3.44 ± 0.28 | 3.52 ± 0.27 | 3.56 ± 0.40 | 3.48 ± 0.34 | 3.50 ± 0.27 | 3.49 ± 0.43 |
| DRP (%) | 77.99 ± 0.22 | 78.08 ± 0.26 | 78.59 ± 0.26 | 78.01 ± 0.23 | 77.83 ± 0.23 | 78.85 ± 0.40 |
| Cr (kg) | 2.58 ± 0.22 A | 2.62 ± 0.21 | 2.69 ± 0.28 B | 2.61 ± 0.34 | 2.62 ± 0.26 | 2.65 ± 0.42 |
| BRM (%) | 31.86 ± 0.24 | 32.23 ± 0.21 | 31.51 ± 0.77 | 32.02 ± 0.31 | 31.89 ± 0.25 | 32.10 ± 0.49 |
| LGM (%) | 18.36 ± 0.11 | 19.23 ± 0.15 | 19.0 ± 0.14 | 19.88 ± 0.05 | 19.56 ± 0.05 | 19.75 ± 0.05 |
| LGB (%) | 4.07 ± 0.26 | 4.37 ± 0.13 | 4.15 ± 0.30 | 4.55 ± 0.08 | 4.58 ± 0.07 | 4.45 ± 0.09 |
| G (%) | 3.83 ± 0.05 | 3.78 ± 0.06 | 3.71 ± 0.08 | 3.76 ± 0.06 | 3.87 ± 0.06 | 3.73 ± 0.08 |
| AF (%) | 1.34 ± 0.05 b | 1.13 ± 0.04 a | 1.28 ± 0.11 | 1.16 ± 0.06 | 1.37 ± 0.06 | 1.19 ± 0.08 |
|
| ||||||
| pH 24 h | 5.80 ± 0.01 | 5.81 ± 0.01 | 5.77 ± 0.02 | 5.78 ± 0.02 | 5.80 ± 0.01 | 5.84 ± 0.02 |
| Colour L* | 58.45 ± 0.39 | 59.32 ± 0.37 | 59.05 ± 0.47 | 58.76 ± 0.49 | 59.13 ± 0.34 | 58.72 ± 0.46 |
| a* | 10.48 ± 0.23 | 10.15 ± 0.21 | 10.66 ± 0.36 | 10.38 ± 0.33 | 10.36 ± 0.20 | 10.37 ± 0.31 |
| b* | 9.28 ± 0.18 | 9.56 ± 0.20 | 9.73 ± 0.32 | 9.64 ± 0.28 | 9.31 ± 0.16 | 9.75 ± 0.22 |
| TL (%) | 24.74 ± 0.47 b | 26.51 ± 0.46 a | 25.32 ± 0.68 | 24.69 ± 0.59 a | 25.14 ± 0.40 ab | 27.46 ± 0.69 b |
| WBS (N) | 18.33 ± 0.39 | 19.13 ± 0.63 | 18.55 ± 0.83 | 18.58 ± 0.66 | 18.04 ± 0.40 | 19.60 ± 0.69 |
* Genotype frequency; A–B Means with different letters within rows differ significantly (p < 0.01); a–b Means with different letters within rows differ significantly (p < 0.05); BW, body weight; DRP, dressing percentage without giblets; Cr, carcass weight; G, proportion of giblets in the carcass; BRM, proportion of breast muscles in the carcass; LGM, proportion of leg muscles in the carcass; LGB, proportion of leg bones in the carcass; AF, proportion of abdominal fat in the carcass; L*, a*, b*, muscle colour: L* (lightness), a* (redness) and b* (yellowness); TL, thermal loss; WBS, Warner–Bratzler shear force.
Association between g.285 C>T SNP of FABP4 gene and g.4290 C>G SNP of FADS2 with FA profile of pectoralis superficialis muscle (TA%).
| Traits | ||||||
|---|---|---|---|---|---|---|
| CC | CG | GG | CC | CT | TT | |
| 14:0 | 1.36 ± 0.01 A | 1.25 ± 0.02 B | 1.29 ± 0.02 | 1.32 ± 0.02 | 1.4 ± 0.2 | 1.40 ± 0.03 |
| 14:1 | 0.29 ± 0.01 A | 0.24 ± 0.01 B | 0.24 ± 0.01 B | 0.27 ± 0.01 | 0.29 ± 0.01 | 0.28 ± 0,02 |
| 15:0 | 0.21 ± 0.01 | 0.213 ± 0.00 | 0.22 ± 0.01 | 0.21 ± 0.01 | 0.23 ± 0.02 | 0.21 ± 0.01 |
| 16:0 | 24.39 ± 0.14 | 25.83 ± 0.69 | 26.18 ± 0.64 | 25.6 ± 0.5 | 24.0 ± 0.5 | 23.6 ± 0.3 |
| 16:1 | 5.14 ± 0.09 A | 4.42 ± 0.13 B | 4.17 ± 0.10 B | 4.70 ± 0.15 | 4.98 ± 0.12 | 5.06 ± 0.12 |
| 17:0 | 0.31 ± 0.01 | 0.34 ± 0.01 | 0.34 ± 0.01 | 0.32 ± 0.01 | 0.30 ± 0.01 | 0.31 ± 0.01 |
| 17:1 | 0.31 ± 0.01 A | 0.28 ± 0.01 B | 0.27 ± 0.01 B | 0.28 ± 0.01 | 0.29 ± 0.01 | 0.29 ± 0.01 |
| 18:0 | 8.36 ± 0.18 A | 9.59 ± 0.22 B | 10.16 ± 0.20 B | 9.43 ± 0.18 | 8.79 ± 0.20 | 8.81 ± 0.29 |
| 18:1 | 41.91 ± 0.37 A | 38.78 ± 0.62 B | 37.68 ± 0.43 B | 39.75 ± 0.34 | 40.9 ± 0.37 | 40.32 ± 0.47 |
| 18:2 | 13.89 ± 0.19 | 13.94 ± 0.22 | 13.72 ± 0.21 | 13.75 ± 0.16 a | 13.77 ± 0.20 b | 14.15 ± 0.17 ab |
| 18:3n-3 | 1.15 ± 0.06 a | 1.01 ± 0.04 | 0.95 ± 0.04 b | 1.15 ± 0.01 | 1.1 ± 0.03 | 1.23 ± 0.02 |
| CLA | 0.21 ± 0.00 A | 0.21 ± 0.00 A | 0.18 ± 0.00 B | 0.19 ± 0.00 a | 0.20 ± 0.00 ab | 0.21 ± 0.00 b |
| 20:0 | 0.05 ± 0.00 a | 0.06 ± 0.01 | 0.06 ± 0.04 b | 0.06 ± 0.00 | 0.06 ± 0.00 | 0.05 ± 0.00 |
| 20:1 | 0.20 ± 0.00 | 0.21 ± 0.01 | 0.21 ± 0.01 | 0.20 ± 0,00 | 0.21 ± 0.00 | 0.20 ± 0.00 |
| 20:2 | 0.11 ± 0.01 Aa | 0.15 ± 0.01 b | 0.18 ± 0.01 B | 0.14 ± 0.01 | 0.13 ± 0.00 | 0.13 ± 0.00 |
| 20:3n-6 | 0.19 ± 0.01 Aa | 0.28 ± 0.03 b | 0.35 ± 0.02 B | 0.26 ± 0.01 | 0.23 ± 0.01 | 0.24 ± 0.01 |
| 20:4 | 0.98 ± 0.07 Aa | 1.69 ± 0.23 b | 2.02 ± 0.17 B | 1.43 ± 0.03 | 1.24 ± 0.02 | 1.34 ± 0.01 |
| 20:5n-3 | 0.06 ± 0.01 Aa | 0.10 ± 0.01 b | 0.12 ± 0.01 B | 0.08 ± 0.00 | 0.08 ± 0.00 | 0.07 ± 0.00 |
| 22:4n-6 | 0.22 ± 0.01 Aa | 0.40 ± 0.05 b | 0.50 ± 0.04 B | 0.35 ± 0.03 | 0.28 ± 0.02 | 0.33 ± 0.03 |
| 22:5 | 0.25 ± 0.01 Aa | 0.41 ± 0.05 b | 0.47 ± 0.04 B | 0.36 ± 0.04 | 0.33 ± 0.03 | 0.32 ± 0.4 |
| 22:6n-3 | 0.19 ± 0.01 Aa | 0.29 ± 0.03 b | 0.36 ± 0.03 B | 0.30 ± 0.02 | 0.26 ± 0.02 | 0.26 ± 0.02 |
Values in table represent least squares mean (LSM ± SE); CLA, conjugated linoleic acid. A–B Means with different letters within rows differ significantly (p < 0.01); a–b Means with different letters within rows differ significantly (p < 0.05).
Least-squares ± S.E. of health quality parameters based on the FA profile (TA%).
| Traits | ||||||
|---|---|---|---|---|---|---|
| CC | CG | GG | CC | CT | TT | |
| SFA | 34.75 ± 0.31 Aa | 37.35 ± 0.89 b | 38.34 ± 0.82 B | 36.58 ± 0.47 | 35.44 ± 0.56 | 35.42 ± 0.86 |
| UFA | 65.14 ± 0.31 Aa | 62.50 ± 0.88 b | 61.49 ± 0.81 B | 63.28 ± 0.46 | 64.43 ± 0.66 | 64.46 ± 0.85 |
| MUFA | 47.87 ± 0.40 A | 43.97 ± 0.62 B | 42.60 ± 0.42 B | 45.03 ± 0.407 | 46.53 ± 0.46 | 45.96 ± 0.62 |
| PUFA | 17.27 ± 0.28 | 18.53 ± 0.54 | 18.89 ± 0.53 | 18.04 ± 0.37 | 17.69 ± 0.37 | 18.28 ± 0.33 |
| n-6/n-3 | 9.76 ± 0.33 | 9.53 ± 0.35 | 9.51 ± 0.31 | 9.82 ± 1.26 | 9.95 ± 1.44 | 9.9 ± 1.33 |
| DFA | 73.51 ± 0.14 | 72.09 ± 0.69 | 71.65 ± 0.64 | 72.72 ± 0.36 | 73.23 ± 0.39 | 73.27 ± 0.60 |
| OFA | 26.39 ± 0.14 | 27.76 ± 0.71 | 28.17 ± 0.65 | 27.14 ± 0.36 | 26.65 ± 0.39 | 26.61 ± 0.60 |
| Index IA | 0.39 ± 0.00 a | 0.44 ± 0.01 | 0.45 ± 0.01 b | 0.42 ± 0.01 | 0.41 ± 0.01 | 0.41 ± 0.01 |
| LA/ALA | 14.84 ± 0.52 a | 14.25 ± 0.62 | 12.88 ± 0.57 b | 14.35 ± 2.42 | 13.89 ± 2.42 | 13.47 ± 2.53 |
SFA = ∑ (C10:0, C12:0, C14:0, C15:0, C16:0, C17:0, C18:0, C20:0); UFA = MUFA + PUFA, MUFA = ∑ (C14:1, C16:1, C17:1, C18:1, C20); PUFA–∑ (C18:2, CLA, C18:3, C20:2, C20:3, C20:4, C20:5, C22:4, C22:5 and C22:6). DFA (hypocholesterolemic fatty acids) = UFA + C18:0; OFA (hypercholesterolemic fatty acids) = SFA–C18:0; PUFA n-6–Σ C20:2, C20:4 and C22:4; PUFA n-3–Σ (C18:3, C20:5, C22:5 and C22:6); PUFA n-3–C18:3, IA (index of atherogenicity) = (Σ C12:0, C14:0 and C16:0)/UFA, LA/ALA = linoleic acid/alpha-linolenic acid. A–B Means with different letters within rows differ significantly (p < 0.01); a–b Means with different letters within rows differ significantly (p < 0.05).